Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1386 per EA under NDC 69315091001. Its NADAC has been published 315 times since Aug 12, 2020.
FDA first approved this application on Feb 20, 2020. Its Orange Book therapeutic-equivalence code is AA.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
diphenoxylate hydrochloride and atropine sulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
Leading Pharma, LLCNDC
69315091001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213413FDA Approved
2/20/2020
TE Code
AA
On Market Since
3/15/2020
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 315 times since Aug 12, 2020, and over the history we have for it it has declined 47.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1386 per EA |
|---|---|
| All-time high | $0.2788 (Sep 16, 2020) |
| All-time low | $0.1298 (Nov 20, 2024) |
| 52-week high | $0.1837 |
| 52-week low | $0.1371 |
| Median price | $0.1940 |
| Average price | $0.1900 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 315 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1386 per EA (NDC 69315091001), effective Aug 19, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 47.1%. It has been tracked across 315 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Aug 12, 2020, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2788 (Sep 16, 2020), with a median of $0.1940 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 69315091001) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.